| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 10/04/2011 | CA2478099C Inhibitors |
| 10/04/2011 | CA2338886C Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 09/29/2011 | WO2011119759A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 09/29/2011 | WO2011060144A3 Compositions and methods to protect cells by blocking entry of pathogen proteins |
| 09/29/2011 | US20110239317 Polynucleotides encoding promyostatin polypeptides |
| 09/29/2011 | US20110237785 Spatially-defined macrocyclic compounds useful for drug discovery |
| 09/29/2011 | US20110237776 Aromatic compounds with sulfur containing ligands |
| 09/29/2011 | US20110237507 Methods of protecting against apoptosis using lipopeptides |
| 09/29/2011 | US20110237493 Dipeptide linked medicinal agents |
| 09/29/2011 | US20110236311 Radiolabelling methods |
| 09/29/2011 | US20110233427 Magnetite-silver heterodimer nanoparticles and their preparation and use for two-photon fluorescence |
| 09/29/2011 | CA2792938A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 09/28/2011 | EP2368901A1 Peptidomimetic protease inhibitors |
| 09/28/2011 | EP2368898A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 09/28/2011 | EP2368878A1 Peptidomimetic protease inhibitors |
| 09/28/2011 | EP2368877A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 09/28/2011 | EP2368561A1 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 09/28/2011 | EP2367954A1 Proteinase k inhibitors, methods and compositions therefor |
| 09/28/2011 | EP2367842A1 Hmg-coa reductase derived peptide and cosmetic or pharmaceutical composition containing same |
| 09/28/2011 | EP2367813A1 Antiviral compounds |
| 09/28/2011 | EP2041159B1 Macrocyclic compounds as antiviral agents |
| 09/28/2011 | EP1945201B1 Calcium receptor activator |
| 09/28/2011 | CN102203115A Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions |
| 09/28/2011 | CN102203114A Piperazine compounds with herbicidal effect |
| 09/28/2011 | CN102199194A Method for preparing dipeptide derivative |
| 09/28/2011 | CN102199111A Process and intermediates for the preparation of hepatitis C virus protease inhibitor |
| 09/28/2011 | CN101597291B 2-aminoacyl tryptophyl-Beta-tetrahydric carboline-3-carboxylic acid carbobenzoxy as well as preparation method and application thereof |
| 09/27/2011 | US8026341 Transfection complexes |
| 09/27/2011 | US8026208 Peptide tyrosinase inhibitors and uses thereof |
| 09/27/2011 | US8026058 PCR hot start by magnesium sequestration |
| 09/27/2011 | CA2463865C Dimeric compounds and their use as anti-viral agents |
| 09/22/2011 | WO2011115819A2 Small molecule inhibitors of muc1 and methods of identifying the same |
| 09/22/2011 | WO2011114071A2 Synthetic cyclopeptide, preparation process and uses |
| 09/22/2011 | US20110230441 Stable bortezomib formulations |
| 09/22/2011 | US20110230419 Iap binding compounds |
| 09/22/2011 | US20110230397 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 09/22/2011 | US20110229568 Michael systems as transglutaminase inhibitors |
| 09/22/2011 | US20110229565 Drug Delivery Composition Comprising a Self-Assembled Gelator |
| 09/22/2011 | US20110229453 Blood coagulation factor inhibitors |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | US20110226621 Target recognition molecule and a method for immobilizing the same |
| 09/22/2011 | CA2793181A1 Nanotubes and compositions thereof |
| 09/21/2011 | EP2366704A1 Inhibitors of serine proteases |
| 09/21/2011 | EP2366027A2 Rapid fret-based diagnosis of bacterial pathogen |
| 09/21/2011 | EP2365980A1 Hepatitis c virus inhibitors |
| 09/21/2011 | EP2365820A2 Endothelium mimicking nanomatrix |
| 09/21/2011 | EP1675835B1 Methods of preparation of dehydro-diketopiperazines in liquid phase or on solid supported phase |
| 09/21/2011 | EP1505963B9 Hepatitis c virus inhibitors |
| 09/21/2011 | CN102197044A Peptide having anti-diabetic activity and use thereof |
| 09/21/2011 | CN102190706A Novel loach protein antihypertensive peptide and preparation method thereof |
| 09/21/2011 | CN102190705A Synthetic method for Arg-Orn dipeptide |
| 09/21/2011 | CN101597289B 2-tryptophanyl-Beta-tetrahydric carboline-3-formyol amino-acid benzyl ester and preparation method and application thereof |
| 09/20/2011 | US8022252 Spatially-defined macrocyclic compounds useful for drug discovery |
| 09/20/2011 | US8022180 Method for preventing and treating Alzheimer's disease |
| 09/20/2011 | US8022172 Clostridial toxin substrate comprising fluorphore, lanthanide donor complex and botulin toxin recognition sequence for use in detecting clostridial protease activity |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8021853 Inhibition of the β3 subunit of L-type Ca2+ channels |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2530611C Biologically active peptide comprising tyrosyl-seryl-valine (ysv) |
| 09/20/2011 | CA2474156C Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c) |
| 09/20/2011 | CA2474035C Macrocyclic peptides active against the hepatitis c virus |
| 09/20/2011 | CA2399832C Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | WO2011112966A1 Bioluminescent assays using cyanobenzothiazole compounds |
| 09/15/2011 | US20110224154 Peptide derivative and composition for promoting tear secretion comprising the same |
| 09/15/2011 | US20110224134 Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
| 09/15/2011 | US20110223254 Functionalized diphenolics and absorbable polymers therefrom |
| 09/15/2011 | US20110223202 Cationic core-shell peptide nonoparticles |
| 09/15/2011 | US20110219982 Antifungal paints and coatings |
| 09/14/2011 | EP2364984A1 Inhibitors of serine proteases |
| 09/14/2011 | EP2364321A1 Hepatitis c virus inhibitors |
| 09/14/2011 | EP2364310A2 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication |
| 09/14/2011 | EP2364309A2 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 09/14/2011 | EP1912997B1 Macrocyclic inhibitors of hepatitis c virus |
| 09/14/2011 | EP1885741B1 Lys-thr dipeptides and their use |
| 09/14/2011 | EP1469869B1 Peptide useful in immunomodulation |
| 09/14/2011 | CN101519428B L-alanyl-L-glutamine compound and synthetic method thereof |
| 09/13/2011 | US8017771 Process for preparing acyclic HCV protease inhibitors |
| 09/13/2011 | US8017729 Nanographite structure/metal nanoparticle composite |
| 09/13/2011 | US8017586 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 09/13/2011 | US8017581 MSH-agonist tripeptide conjugates |
| 09/13/2011 | US8017571 Peptides derived from human BPLP protein |
| 09/13/2011 | US8017343 Cytokine zalpha11 ligand antibodies and methods of use |
| 09/13/2011 | CA2396937C Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/09/2011 | WO2011109355A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | WO2011107948A2 Ligands of insulin degrading enzyme and their uses |
| 09/09/2011 | WO2011106898A1 Methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases |
| 09/09/2011 | CA2791651A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | CA2791535A1 Methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases |
| 09/08/2011 | US20110218343 Small molecule inhibitors of rotamase enzyme activity |
| 09/08/2011 | US20110218154 Histone deacetylases, and uses related thereto |
| 09/08/2011 | US20110218142 Inhibitors of Dipeptidylpeptidase IV |
| 09/08/2011 | US20110217324 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 09/08/2011 | US20110217241 Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging |
| 09/07/2011 | EP2363475A1 Screening method, composition containing substance selected by the screening method, and binding substance |
| 09/07/2011 | EP2363424A1 Block copolymers for multifunctional self-assembled systems |
| 09/07/2011 | EP2363405A1 Anti-infarction molecules |
| 09/07/2011 | EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases |
| 09/07/2011 | EP2362880A1 Tumor necrosis factor alpha inhibiting peptides and uses thereof |